Pokaż caÅy numer - FPN - Farmaceutyczny PrzeglÄ d Naukowy
Pokaż caÅy numer - FPN - Farmaceutyczny PrzeglÄ d Naukowy Pokaż caÅy numer - FPN - Farmaceutyczny PrzeglÄ d Naukowy
copyright © 2009 Grupa dr. A. R. Kwiecińskiego ISSN 1425-5073Topic of the Meeting‘Interfacing Chemical Biology and Drug Discovery’Session topics:- Target selection and validation for drug discoverychemicalbiology- Hit to Lead: identification, selection, development- Case-studies: from bench to bedside- Physico-chemical tools and structural studies- Synthetic chemistry: new frontiers impacting drugdiscoveryScientific programThe following distinguished speakers have already accepted to present a lecture:Dr Martin ANDREWS (Galapagos NV, Mechelen, Belgium )Dr Louis-David CANTIN (AstraZeneca, Montréal, Canada)Pr David CRICH (ICSN-CNRS, Gif-sur-Yvette, France)Pr Maxime DAHAN (Ecole Normale Supérieure, Paris, France)Pr Ben DAVIS (University of Oxford, Great Britain)Dr Bruno FIGADÈRE (Université Paris-Sud 11, Châtenay-Malabry, France)Dr Gilles GOSSELIN (Idenix Sarl, Montpellier, France)Dr Gilles GUICHARD (IECB, Bordeaux, France)Dr Michael HAHN (Bayer HealthCare, Wuppertal, Germany)Pr Arnaud HAUDRECHY (Université de Reims Champagne-Ardenne, France)Dr Eric JNOFF (UCB Pharma, Braine-l'Alleud, Belgium)Dr Romano KROEMER (Sanofi-Aventis, Vitry/Seine, France)Dr Cynthia MARYANOFF (Cordis, a J&J Company, Spring House, USA)Dr Bruce MARYANOFF (Scripps, San Diego, USA)Dr Laurent MICOUIN (Université Paris Descartes, France)Pr Christa MÜLLER (University of Bonn, Germany)Dr Sylviane MULLER (IBMC-CNRS, Strasbourg, France)Pr Dario NERI (ETH-Zürich, Switzerland)Dr Olivier NOSJEAN (Servier, Croissy/Seine, France)Dr Michel PEREZ (Pierre Fabre, Castres, France)Dr Philippe PFLIEGER (F. Hoffmann-La Roche, Basel, Switzerland)Dr Vipul K. PATEL (GlaxoSmithKline, Stevenage, Great Britain)Pr Claudiu SUPURAN (University of Firenze, Italy)Dr Léo WIDLER (Novartis, Basel, Switzerland)Speaker to be announced (Galderma R&D, Sophia-Antipolis, France)Novembrer 23, 20097
- Page 1: copyright © 2009 Grupa dr. A. R. K
- Page 4 and 5: Zdj. Zygmunt WieczorekSzanowni Pań
- Page 8: Farm Przegl Nauk, 2009,11Scientific
- Page 11 and 12: Farm Przegl Nauk, 2009,11, 11-14cop
- Page 13 and 14: copyright © 2009 Grupa dr. A. R. K
- Page 15 and 16: Farm Przegl Nauk, 2009,11, 15-19cop
- Page 17 and 18: copyright © 2009 Grupa dr. A. R. K
- Page 19 and 20: copyright © 2009 Grupa dr. A. R. K
- Page 21 and 22: copyright © 2009 Grupa dr. A. R. K
- Page 23 and 24: Nazwa sondySymbolgenuNazwa kodowane
- Page 25 and 26: copyright © 2009 Grupa dr. A. R. K
- Page 30 and 31: Farm Przegl Nauk, 2009,11Jak częst
- Page 32: Farm Przegl Nauk, 2009,11cji. Na ś
- Page 36 and 37: Farm Przegl Nauk, 2009,11WnioskiUzy
- Page 38 and 39: Farm Przegl Nauk, 2009,1140-70 nm.
- Page 40 and 41: Farm Przegl Nauk, 2009,11lek antyan
- Page 42 and 43: Farm Przegl Nauk, 2009,11, 42-47Oce
- Page 44 and 45: Farm Przegl Nauk, 2009,11• MPR -
- Page 46 and 47: Farm Przegl Nauk, 2009,11na ryzyko
- Page 48 and 49: Farm Przegl Nauk, 2009,11INFORMATIO
- Page 50: FarmaceutycznyPISMO POD PATRONATEM
copyright © 2009 Grupa dr. A. R. Kwiecińskiego ISSN 1425-5073Topic of the Meeting‘Interfacing Chemical Biology and Drug Discovery’Session topics:- Target selection and validation for drug discoverychemicalbiology- Hit to Lead: identification, selection, development- Case-studies: from bench to bedside- Physico-chemical tools and structural studies- Synthetic chemistry: new frontiers impacting drugdiscoveryScientific programThe following distinguished speakers have already accepted to present a lecture:Dr Martin ANDREWS (Galapagos NV, Mechelen, Belgium )Dr Louis-David CANTIN (AstraZeneca, Montréal, Canada)Pr David CRICH (ICSN-CNRS, Gif-sur-Yvette, France)Pr Maxime DAHAN (Ecole Normale Supérieure, Paris, France)Pr Ben DAVIS (University of Oxford, Great Britain)Dr Bruno FIGADÈRE (Université Paris-Sud 11, Châtenay-Malabry, France)Dr Gilles GOSSELIN (Idenix Sarl, Montpellier, France)Dr Gilles GUICHARD (IECB, Bordeaux, France)Dr Michael HAHN (Bayer HealthCare, Wuppertal, Germany)Pr Arnaud HAUDRECHY (Université de Reims Champagne-Ardenne, France)Dr Eric JNOFF (UCB Pharma, Braine-l'Alleud, Belgium)Dr Romano KROEMER (Sanofi-Aventis, Vitry/Seine, France)Dr Cynthia MARYANOFF (Cordis, a J&J Company, Spring House, USA)Dr Bruce MARYANOFF (Scripps, San Diego, USA)Dr Laurent MICOUIN (Université Paris Descartes, France)Pr Christa MÜLLER (University of Bonn, Germany)Dr Sylviane MULLER (IBMC-CNRS, Strasbourg, France)Pr Dario NERI (ETH-Zürich, Switzerland)Dr Olivier NOSJEAN (Servier, Croissy/Seine, France)Dr Michel PEREZ (Pierre Fabre, Castres, France)Dr Philippe PFLIEGER (F. Hoffmann-La Roche, Basel, Switzerland)Dr Vipul K. PATEL (GlaxoSmithKline, Stevenage, Great Britain)Pr Claudiu SUPURAN (University of Firenze, Italy)Dr Léo WIDLER (Novartis, Basel, Switzerland)Speaker to be announced (Galderma R&D, Sophia-Antipolis, France)Novembrer 23, 20097